Uncovering the roles of intermediate filaments in apoptosis

Methods in Cell Biology

Volumn 2004, Issue 78, 2004, Pages 95-129

  Marceau, Normand ^a,b   Gilbert, Stéphane ^a,b   Loranger, Anne ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOKERATIN 18; CYTOKERATIN 8; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KRT18 PROTEIN, HUMAN; KRT8 PROTEIN, MOUSE;

ANIMAL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE TECHNIQUE; CYTOLOGY; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; INTERMEDIATE FILAMENT; LIVER CELL; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CASPASES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HEPATOCYTES; HUMANS; INTERMEDIATE FILAMENT PROTEINS; INTERMEDIATE FILAMENTS; KERATIN-18; KERATIN-8; KERATINS; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NEOPLASMS;

EID: 14244254727     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(04)78005-x     Document Type: Review

References (137)

1. Ameen, N. A., Figueroa, Y., and Salas, P. J. (2001). Anomalous apical plasma membrane phenotype in CKS-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia. J. Cell Sci. 114, 563-575.
2. Andra, K., Nikolic, B., Stocher, M., Drenckhahn, D., and Wiche, G. (1998). Not just scaffolding: Plectin regulates actin dynamics in cultured cells. Genes Dev. 12, 3442-3451.
3. Ashkenazi, A., and Dixit, V. M. (1998). Death receptors: Signaling and modulation. Science 281, 1305-1308.
4. Ausubel, F. M. (1994). "Current Protocols in Molecular Biology." John Wiley & Sons, Inc. New York.
5. Badock, V., Steinhusen, U., Bommert, K., Wittmann-Liebold, B., and Otto, A. (2001). Apoptosis-induced cleavage of keratin 15 and keratin 17 in a human breast epithelial cell line. Cell Death Differ. 8, 308-315.
6. Baker, S. J., and Reddy, E. P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9.
7. Baribault, H., Blouin, R., Bourgon, L., and Marceau, N. (1989). Epidermal growth factor-induced selective phosphorylation of cultured rat hepatocyte 55-kD cytokeratin before filament reorganization and DNA synthesis. J. Cell Biol. 109, 1665-1676.
8. Baribault, H., Penner, J., Iozzo, R. V., and Wilson-Heiner, M. (1994). Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8, 2964-2973.
9. Baribault, H., Price, J., Miyai, K., and Oshima, R. G. (1993). Mid-gestational lethality in mice lacking keratin 8. Genes Dev. 7, 1191-1202.
10. Bauman, P. A., Dalton, W. S., Anderson, J. M., and Cress, A. E. (1994). Expression of cytokeratin confers multiple drug resistance. Proc. Natl. Acad. Sci. USA 91, 5311-5314.
11. Bojarski, C., Weiske, J., Schoneberg, T., Schroder, W., Mankertz, J., Schulzke, J. D., Florian, P., Fromm, M., Tauber, R., and Huber, O. (2004). The specific fates of tight junction proteins in apoptotic epithelial cells. J. Cell Sci. 117, 2097-2107.
12. Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K. J., and Cryns, V. L. (2001). Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ. 8, 443-4450.
13. Cadrin, M., Marceau, N., and Baribault, H. (1996). Griseofulvin hepatotoxicity-related effects in keratin 8 deficient FVB/N mice. Mol. Biol. Cell 6S, 2171.
14. Caulin, C., Salvesen, G. S., and Oshima, R. G. (1997). Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138, 1379-1394.
15. Caulin, C., Ware, C. F., Magin, T. M., and Oshima, R. G. (2000). Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 149, 17-22.
16. Chen, F., Chang, R., Trivedi, M., Capetanaki, Y., and Cryns, V. L. (2003). Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis. J. Biol. Chem. 278, 6848-6853.
17. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965.
18. Coulombe, P. A., Bousquet, O., Ma, L., Yamada, S., and Wirtz, D. (2000). The 'ins' and 'outs' of intermediate filament organization. Trends Cell Biol. 10, 420-428.
19. Coulombe, P. A., and Omary, M. B. (2002). 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14, 110-122.
20. Deschênes, J., Valet, J. P., and Marceau, N. (1979). Hepatocytes from newborn and weanling rats in monolayer culture: Isolation by perfusion, fibronectin-mediated adhesion, spreading, and functional activities. In Vitro 16(8), 722-730.
21. Dinsdale, D., Lee, J. C., Dewson, G., Cohen, G. M., and Peter, M. E. (2004). Intermediate filaments control the intracellular distribution of caspases during apoptosis. Am. J. Pathol. 164, 395-407.
22. Ellis, P. A., Smith, I. E., and Dowsett, M. (1996). Apoptosis-its role in tumour growth and therapy. Cytopathology 7, 201-203.
23. Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
24. Engvall, E., 61nd Ruoslahti, E. (1977). Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 20, 1-5.
25. Feng, G., and Kaplowitz, N. (2000). Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. J. Clin. Invest. 105, 329-339.
26. Fox, J. G., Yan, L., Shames, B., Campbell, J., Murphy, J. C., and Li, X. (1996). Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect. Immun. 64, 3673-3681.
27. Fuchs, E. (1996). The cytoskeleton and disease: Genetic disorders of intermediate filaments. Annu. Rev. Genet. 30, 197-231.
28. Fuchs, E., and Cleveland, D. W. (1998). A structural scaffolding of intermediate filaments in health and disease. Science 279, 514-518.
29. Fuchs, E., and Karakesisoglou, I. (2001). Bridging cytoskeletal intersections. Genes Dev. 15, 1-14.
30. Fuchs, E., and Weber, K. (1994). Intermediate filaments: Structure, dynamics, function, and disease. Annu. Rev. Biochem. 63, 345-382.
31. Fulda, S., Meyer, E., and Debatin, K. M. (2000). Metabolic inhibitors sensitize for CD95 (APO-1/ Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res. 60, 3947-3956.
32. Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., and Runkel, L. (1995). Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
33. Gilbert, S., Loranger, A., Daigle, N., and Marceau, N. (2001). Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J. Cell Biol. 154, 763-773.
34. Gilbert, S., Loranger, A., and Marceau, N. (2004). Keratins modulate c-Flip/ERK1/2 antiapoptotic signaling in simple epithelial cells. Mol. Cell. Biol. 24, 7072-7081.
35. Gill, J. H., James, N. H., Roberts, R. A., and Dive, C. (1998). The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFb1, DNA damage and Fas. Carcinogenesis 19(2), 299-304.
36. Grassi, A., Susca, M., Ferri, S., Gabusi, E., D'Errico, A., Farina, G., Maccariello, S., Zauli, D., Bianchi, F. B., and Ballardini, G. (2004). Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: Timing and patterns of positivity on frozen and paraffin-embedded sections. Am. J. Clin. Pathol. 121, 211-219.
37. Green, K. J., and Gaudry, C. A. (2000). Are desmosomes more than tethers for intermediate filaments? Nat. Rev. Mol. Cell. Biol. 1, 208-216.
38. Green, K. J., Kowalczyk, A. P., Bornslaeger, E. A., Palka, H. L., and Norvell, S. M. (1998). Desmosomes: Integrators of mechanical integrity in tissues. Biol. Bull. 194, 374-376; discussion 376-377.
39. Guilhot, S., Miller, T., Cornman, G., and Isom, H. C. (1996). Apoptosis induced by tumor necrosis factor-alpha in rat hepatocyte cell lines expressing hepatitis B virus. Am. J. Pathol. 148, 801-814.
40. Hara, A., Yoshimi, N., Yamada, Y., Matsunaga, K., Kawabata, K., Sugie, S., and Mori, H. (2000). Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice. Br. J. Cancer 82, 467-471.
41. Hashimoto, M., Inoue, S., Ogawa, S., Conrad, C., Muramatsu, M., Shackelford, D., and Masliah, E. (1998). Rapid fragmentation of vimentin in human skin fibroblasts exposed to tamoxifen: A possible involvement of caspase-3. Biochem. Biophys. Res. Commun. 247, 401-406.
42. He, T., Stepulak, A., Holmstrom, T. H., Omary, M. B., and Eriksson, J. E. (2002). The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-jun-N-terminal kinase. J. Biol. Chem. 277, 10767-10774.
43. Hendrix, M. J., Seftor, E. A., Chu, Y. W., Trevor, K. T., and Seftor, R. E. (1996). Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507-525.
44. Hendrix, M. J., Seftor, E. A., Seftor, R. E., Gardner, L. M., Boldt, H. C., Meyer, M., Pe'er, J., and Folberg, R. (1998). Biologic determinants of uveal melanoma metastatic phenotype: Role of intermediate filaments as predictive markers. Lab. Invest. 78, 153-163.
45. Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
46. Herrmann, H., and Aebi, U. (2000). Intermediate filaments and their associates: Multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 12, 79-90.
47. Herrmann, H., Hesse, M., Reichenzeller, M., Aebi, U., and Magin, T. M. (2003). Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation. Int. Rev. Cytol. 223, 83-175.
48. Hesse, M., Franz, T., Tamai, Y., Taketo, M. M., and Magin, T. M. (2000). Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality. Embo J. 19, 5060-5070.
49. Hesse, M., Magin, T. M., and Weber, K. (2001). Genes for intermediate filament proteins and the draft sequence of the human genome: Novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18. J. Cell Sci. 114, 2569-2575.
50. Hesse, M., Berg, T., Wiedenmann, B., Spengler, U., Woitas, K. P., and Magin, T. M. (2004). A frequent keratin 8 pL227L polymorphism, but no point mutations in keratin 8 and 18 genes, in pateitns with various liver disorders. J. Med. Genet. 41, e42.
51. Holmstrom, T. H., Schmitz, I., Soderstrom, T. S., Poukkula, M., Johnson, V. L., Chow, S. C., Krammer, P. H., and Eriksson, J. E. (2000). MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19, 5418-5428.
52. Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
53. Inada, H., Izawa, I., Nishizawa, M., Fujita, E., Kiyono, T., Takahashi, T., Momoi, T., and Inagaki, M. (2001). Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol. 155, 415-426.
54. Jaquemar, D., Kupriyanov, S., Wankell, M., Avis, J., Benirschke, K., Baribault, H., and Oshima, R. G. (2003). Keratin 8 protection of placental barrier function. J. Cell Biol. 161, 749-756.
55. Julien, J. P. (1999). Neurofilament functions in health and disease. Curr. Opin. Neurobiol. 9, 554-560.
56. Julien, J. P., and Beaulieu, J. M. (2000). Cytoskeletal abnormalities in amyotrophic lateral sclerosis: Beneficial or detrimental effects? J. Neurol. Sci. 180, 7-14.
57. Kaufmann, S. H., and Earnshaw, W. C. (2000). Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49.
58. Kaufmann, S. H., and Gores, G. J. (2000). Apoptosis in cancer: Cause and cure. Bioessays 22, 1007-1017.
59. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
60. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., and Peter, M. E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588.
61. Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., and Ashkenazi, A. (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611-620.
62. Korfali, N., Ruchaud, S., Loegering, D., Bernard, D., Dingwall, C., Kaufmann, S. H., and Earnshaw, W. C. (2004). Caspase-7 gene disruption reveals an involvement of the enzyme during the early stages of apoptosis. J. Biol. Chem. 279, 1030-1039.
63. Kramer, G., Erdal, H., Mertens, H. J., Nap, M., Mauermann, J., Steiner, G., Marberger, M., Biven, K., Shoshan, M. C., and Linder, S. (2004). Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 64, 1751-1756.
64. Krammer, P. H. (1999). CD95(APO-1/Fas)-mediated apoptosis: Live and let die. Adv. Immunol. 71, 163-210.
65. Ku, N. O., and Omary, M. B. (1997). Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J. Biol. Chem. 272, 7556-7564.
66. Ku, N. O., and Omary, M. B. (2000). Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J. Cell Biol. 149, 547-552.
67. Ku, N. O., and Omary, M. B. (2001). Effect of mutation and phosphorylation of type I keratins on their caspase-mediated degradation. J. Biol. Chem. 276, 26792-26798.
68. Ku, N. O., Azhar, S., and Omary, M. B. (2002a). Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: Modulation by a keratin 1-like disease causing mutation. J. Biol. Chem. 277, 10775-10782.
69. Ku, N. O., Liao, J., Chou, C. F., and Omary, M. B. (1996a). Implications of intermediate filament protein phosphorylation. Cancer Metastasis Rev. 15, 429-411.
70. Ku, N. O., Liao, J., and Omary, M. B. (1997). Apoptosis generates stable fragments of human type I keratins. J. Biol. Chem. 272, 33197-33203.
71. Ku, N. O., Liao, J., and Omary, M. B. (1998). Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J. 17, 1892-1906.
72. Ku, N. O., Michie, S., Resurreccion, E. Z., Broome, R. L., and Omary, M. B. (2002b). Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc. Natl. Acad. Sci. USA 99, 4373-4378.
73. Ku, N. O., Michie, S. A., Soetikno, R. M., Resurreccion, E. Z., Broome, R. L., Oshima, R. G., and Omary, M. B. (1996b). Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J. Clin. Invest. 98, 1034-1046.
74. Ku, N. O., Soetikno, R. M., and Omary, M. B. (2003). Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology 37, 1006-1014.
75. Ku, N. O., Zhou, X., Toivola, D. M., and Omary, M. B. (1999). The cytoskeleton of digestive epithelia in health and disease. Am. J. Physiol 277, G1108-G1137.
76. Kumar, S. (1999). Mechanisms mediating caspase activation in cell death. Cell Death Differ. 6, 1060-1066.
77. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
78. Lane, E. B., Hogan, B. L., Kurkinen, M., and Garrels, J. I. (1983). Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 303, 701-704.
79. Lazebnik, Y. A., Takahashi, A., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. (1995). Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA 92, 9042-9046.
80. Lee, J. C., Schickling, O., Stegh, A. H., Oshima, R. G., Dinsdale, D., Cohen, G. M., and Peter, M. E. (2002). DEDD regulates degradation of intermediate filaments during apoptosis. J. Cell Biol. 158, 1051-1066.
81. Leers, M. P., Kolgen, W., Bjorklund, V., Bergman, T., Tribbick, G., Persson, B., Bjorklund, P., Ramaekers, F. C., Bjorklund, B., Nap, M., Jornvall, H., and Schutte, B. (1999). Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187, 567-572.
82. Leung, C. L., Green, K. J., and Liem, R. K. (2002). Plakins: A family of versatile cytolinker proteins. Trends Cell Biol. 12, 37-45.
83. Liao, J., Ku, N. O., and Omary, M. B. (1997). Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 272, 7565-7573.
84. Loranger, A., Duclos, S., Grenier, A., Price, J., Wilson-Heiner, M., Baribault, H., and Marceau, N. (1997). Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am. J. Pathol. 151, 1673-1683.
85. MacFarlane, M., Merrison, W., Dinsdale, D., and Cohen, G. M. (2000). Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J. Cell Biol. 148, 1239-1254.
86. Magin, T. M., Schroeder, R., Leitgeb, S., Wanninger, F., Zatloukal, K., Grund, C., and Melton, D. W. (1998). Lessons from keratin 18 knockout mice: Formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J. Cell Biol. 140, 1441-1451.
87. Marceau, N., and Loranger, A. (1995). Cytokeratin expression, fibrillar organization, and subtle function in liver cells. Biochem. Cell Biol. 73, 619-625.
88. Marceau, N., Blouin, M. J., Germain, L., and NoÎl, M. (1989). Role of different epithelial cell types in liver ontogenesis, regeneration and neoplasia. In Vitro Cell. Dev. Biol. 25(4), 336-341.
89. Marceau, N., Loranger, A., Gilbert, S., Daigle, N., and Champetier, S. (2001). Keratin-mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease. Biochem. Cell Biol. 79, 543-555.
90. Martin, S. J., and Green, D. R. (1995). Protease activation during apoptosis: death by a thousand cuts? Cell 82, 349-352.
91. McGowan, K., and Coulombe, P. A. (1998). The wound repair-associated keratins 6, 16, and 17. Insights into the role of intermediate filaments in specifying keratinocyte cytoarchitecture. Subcell. Biochem. 31, 173-204.
92. McGowan, K. M., Tong, X., Colucci-Guyon, E., Langa, F., Babinet, C., and Coulombe, P. A. (2002). Keratin 17 null mice exhibit age- and strain-dependent alopecia. Genes Dev. 16, 1412-1422.
93. McLean, W. H. I., and Lane, E. B. (1995). Intermediate filaments in disease. Curr. Opin. Cell Biol. 7, 118-125.
94. Moll, R., Franke, W. W., and Schiller, D. L. (1982). The catalog of human cytokeratins; patterns of expression in normal epithelia, tumors and cultured cells. Cell 31, 11-24.
95. Morishima, N. (1999). Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action. Genes Cells 4, 401-414.
96. Nagata, S. (1999). Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55.
97. Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., and Nagata, S. (1994). Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215, 332-337.
98. Oberhammer, F. A., Hochegger, K., Froschl, G., Tiefenbacher, R., and Pavelka, M. (1994). Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B, without enhanced activation of cdc2 kinase. J. Cell Biol. 126, 827-837.
99. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993). Lethal effect of the anti-fas antibody in mice. Nature 364, 806-808.
100. Omary, M. B., and Ku, N. O. (1997). Intermediate filament proteins of the liver: Emerging disease association and functions. Hepatology 25, 1043-1048.
101. Omary, M. B., Ku, N. O., Liao, J., and Price, D. (1998). Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell. Biochem. 31, 105-140.
102. Orth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., and Dixit, V. M. (1996). The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271, 16443-16446.
103. Oshima, R. G. (2002). Apoptosis and keratin intermediate filaments. Cell Death Differ. 9, 486-492.
104. Oshima, R. G., and Baribault, H. (1992). Inactivation of keratin genes by gene targeting: A perspective. J. Dermatol. 19, 786-789.
105. Oshima, R. G., Baribault, H., and Caulin, C. (1996). Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev. 15, 445-471.
106. Owens, D. W., and Lane, E. B. (2003). The quest for the function of simple epithelial keratins. Bioessays 25, 748-758.
107. Paladini, R. D., and Coulombe, P. A. (1998). Directed expression of keratin 16 to the progenitor basal cells of transgenic mouse skin delays skin maturation. J. Cell Biol. 142, 1035-1051.
108. Paladini, R. D., Takahashi, K., Bravo, N. S., and Coulombe, P. A. (1996). Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J. Cell Biol. 132, 381-397.
109. Paramio, J. M., and Jorcano, J. L. (2002). Beyond structure: Do intermediate filaments modulate cell signalling? Bioessays 24, 836-844.
110. Prasad, S., Soldatenkov, V. A., Srinivasarao, G., and Dritschilo, A. (1998). Identification of keratins 18, 19 and heat-shock protein 90 beta as candidate substrates of proteolysis during ionizing radiation-induced apoptosis of estrogen-receptor negative breast tumor cells. Int. J. Oncol. 13, 757-764.
111. Prasad, S., Soldatenkov, V. A., Srinivasarao, G., and Dritschilo, A. (1999). Intermediate filament proteins during carcinogenesis and apoptosis [review]. Int. J. Oncol. 14, 563-570.
112. Rao, L., Perez, D., and White, E. (1996). Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135, 1441-1455.
113. Ruchaud, S., Korfali, N., Villa, P., Kottke, T. J., Dingwall, C., Kaufmann, S. H., and Earnshaw, W. C. (2002). Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J. 21, 1967-1977.
114. Ruhrberg, C., and Watt, F. M. (1997). The plakin family: Versatile organizers of cytoskeletal architecture. Curr. Opin. Genet. Dev. 7, 392-397.
115. Santos, M., Paramio, J. M., Bravo, A., Ramirez, A., and Jorcano, J. L. (2002). The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J. Biol. Chem. 277, 19122-19130.
116. Sarraf, C. E., Horgan, M., Edwards, R. J., and Alison, M. R. (1997). Reversal of phenobarbital-induced hyperplasia and hypertrophy in the livers of lpr mice. Int. J. Exp. Pathol. 78, 49-56.
117. Shames, B., Fox, J. G., Dewhirst, F., Yan, L., Shen, Z., and Taylor, N. S. (1995). Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol. 33, 2968-2972.
118. Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., and Walczak, H. (2000). FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12, 599-609.
119. Stegh, A. H., Herrmann, H., Lampel, S., Weisenberger, D., Andra, K., Seper, M., Wiche, G., Krammer, P. H., and Peter, M. E. (2000). Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol. Cell. Biol. 20, 5665-5679.
120. Strnad, P., Windoffer, R., and Leube, R. E. (2001). In vivo detection of cytokeratin filament network breakdown in cells treated with the phosphatase inhibitor okadaic acid. Cell Tissue Res. 306, 277-293.
121. Strnad, P., Windoffer, R., and Leube, R. E. (2002). Induction of rapid and reversible cytokeratin filament network remodeling by inhibition of tyrosine phosphatases. J. Cell Sci. 115, 4133-4148.
122. Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K., and Denk, H. (2002). Mallory body-a disease-associated type of sequestosome. Hepatology 35, 1053-1062.
123. Suarez-Huerta, N., Lecocq, R., Mosselmans, R., Galand, P., Dumont, J. E., and Robaye, B. (2000). Myosin heavy chain degradation during apoptosis in endothelial cells. Cell Prolif. 33, 101-114.
124. Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. (1996). Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 93, 8395-8400.
125. Toivola, D. M., Nieminen, M. I., Hesse, M., He, T., Baribault, H., Magin, T. M., Omary, M. B., and Eriksson, J. E. (2001). Disturbances in hepatic cell-cycle regulation in mice with assembly-deficient keratins 8/18. Hepatology 34, 1174-1183.
126. Tran, S. E., Holmstrom, T. H., Ahonen, M., Kahari, V. M., and Eriksson, J. E. (2001). MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276, 16484-16490.
127. Tschopp, J., Irmler, M., and Thome, M. (1998). Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10, 552-558.
128. Valavanis, C., Naber, S., and Schwartz, L. M. (2001). In situ detection of dying cells in normal and pathological tissues. Methods Cell Biol. 66, 393-415.
129. van Engeland, M., Kuijpers, H. J., Ramaekers, F. C., Reutelingsperger, C. P., and Schutte, B. (1997). Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp. Cell Res. 235, 421-430.
130. Viard-Leveugle, I., Bullani, R. R., Meda, P., Micheau, O., Limat, A., Saurat, J. H., Tschopp, J., and French, L. E. (2003). Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J. Biol. Chem. 278, 6183-6188.
131. Walker, P. R., Testolin, L., Armato, U., Marceau, N., Gourdeau, H., and Sikorska, M. (1995). Modulation of apoptosis by oncogenes. In "Apoptosis in Hormone-Dependent Cancers" (M. Tenniswood and H. Michna, eds.), Vol. 14, p. 248. Springer-Verglag, New York.
132. Weber, K., Plessmann, U., and Ulrich, W. (1989). Cytoplasmic intermediate filament proteins of invertebrates are closer to nuclear lamins than are vertebrate intermediate filament proteins: Sequence characterization of two muscle proteins of a nematode. EMBO J. 8, 3221-3227.
133. Weiske, J., Schoneberg, T., Schroder, W., Hatzfeld, M., Tauber, R., and Huber, O. (2001). The fate of desmosomal proteins in apoptotic cells. J. Biol. Chem. 276, 41175-41181.
134. Wiche, G. (1998). Role of plectin in cytoskeleton organization and dynamics. J. Cell Sci. 111, 2477-2486.
135. Wyllie, A. H., Kerr, J. F., and Currie, A. R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
136. Yoneda, K., Furukawa, T., Zheng, Y. J., Momoi, T., Izawa, I., Inagaki, M., Manabe, M., and Inagaki, N. (2004). An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor alpha-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex. J. Biol. Chem. 279, 7296-7303.
137. Zheng, T. S., and Flavell, R. A. (1999). Apoptosis. All's well that ends dead. Nature 400, 410-411.